Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Modalis Therapeutics Corporation (JP:4883)
:4883
4883 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥62.00 - ¥203.00
Previous CloseN/A
Volume5.80M
Average Volume (3M)N/A
Market Cap
¥7.15B
Enterprise Value¥2.48B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-52.59
Shares Outstanding69,404,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Modalis Therapeutics Corporation News
PremiumCompany Announcements
Modalis Secures Japanese Patent for Pioneering Gene Therapy
PremiumCompany Announcements
JCR and Modalis Advance Joint Gene Therapy Research
PremiumCompany Announcements
Modalis Therapeutics Reports Loss Due to Electronic Fraud Incident
PremiumCompany Announcements
Modalis Therapeutics Reports Positive Foreign Exchange GainsPremiumCompany Announcements
Modalis Therapeutics Achieves FDA Orphan Drug Status
PremiumCompany Announcements
Modalis Therapeutics Earns FDA Rare Pediatric Disease DesignationPremiumCompany Announcements
Modalis Therapeutics Unveils Groundbreaking Gene Therapy
PremiumCompany Announcements
Modalis Gains Japanese Patent for DM1 Gene Therapy---
4883 FAQ
What was Modalis Therapeutics Corporation’s price range in the past 12 months?
Modalis Therapeutics Corporation lowest stock price was ¥62.00 and its highest was ¥203.00 in the past 12 months.
What is Modalis Therapeutics Corporation’s market cap?
Modalis Therapeutics Corporation’s market cap is ¥7.15B.
When is Modalis Therapeutics Corporation’s upcoming earnings report date?
Modalis Therapeutics Corporation’s upcoming earnings report date is Feb 13, 2025 which is tomorrow.
How were Modalis Therapeutics Corporation’s earnings last quarter?
Modalis Therapeutics Corporation released its earnings results on Nov 07, 2024. The company reported -¥5.23 earnings per share for the quarter, missing the consensus estimate of N/A by -¥5.23.
Is Modalis Therapeutics Corporation overvalued?
According to Wall Street analysts Modalis Therapeutics Corporation’s price is currently Overvalued.
Does Modalis Therapeutics Corporation pay dividends?
Modalis Therapeutics Corporation does not currently pay dividends.
What is Modalis Therapeutics Corporation’s EPS estimate?
Modalis Therapeutics Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modalis Therapeutics Corporation have?
Modalis Therapeutics Corporation has 69,404,000 shares outstanding.
What happened to Modalis Therapeutics Corporation’s price movement after its last earnings report?
Modalis Therapeutics Corporation reported an EPS of -¥5.23 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.613%.
Which hedge fund is a major shareholder of Modalis Therapeutics Corporation?
Currently, no hedge funds are holding shares in JP:4883
---
Technical Analysis
SanBio Co
―
NanoCarrier Co., Ltd.
―
RaQualia Pharma Inc.
―
Chiome Bioscience Inc.
―
Kidswell Bio Corporation
―
---